Abeer Dagra*, Mac Lyerly, Brandon Lucke-Wold
College of Medicine, University of Florida, Gainesville, Florida, USA
*Corresponding Author: Abeer Dagra, College of Medicine, University of Florida, Gainesville, Florida, USA; Email: [email protected]
Received Date: March 9, 2023
Publication Date: April 26, 2023
Citation: Dagra A, et al. (2023). Encephalitis and Meningitis: Indications for Intervention. Clin Res. 4(1):8.
Copyright: Dagra A, et al. © (2023).
Meningitis and encephalitis are characterized by inflammation of the meninges and brain parenchyma, respectively. The blood-brain barrier normally acts as a protective barrier against inflammation in the central nervous system (CNS), but its compromise requires prompt diagnosis and treatment to prevent morbidity and mortality. Optimizing therapy for meningitis and encephalitis can expedite resolution of symptoms, mitigating the risk of neuronal injury and minimizing potential long-term neurological sequelae. This paper aims to provide a comprehensive overview of the etiology and pathophysiology of meningitis and encephalitis, discussing the diagnostic criteria, and emphasizing the clinical indications for treatments, including current treatment strategies, and emerging therapeutic approaches.
Keywords: Meningitis; Encephalitis; Meningoencephalitis; ICP; CNS inflammation; Diagnostic criteria; Meningitis treatment; Encephalitis treatment; Emerging therapies; Immunomodulatory therapies